Aspiriant LLC Purchases 8,547 Shares of Ambev S.A. (NYSE:ABEV)

Aspiriant LLC raised its position in Ambev S.A. (NYSE:ABEV) by 34.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,635 shares of the company’s stock after acquiring an additional 8,547 shares during the period. Aspiriant LLC’s holdings in Ambev were worth $62,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Crossmark Global Holdings Inc. grew its stake in Ambev by 17.4% during the 4th quarter. Crossmark Global Holdings Inc. now owns 113,416 shares of the company’s stock worth $210,000 after buying an additional 16,833 shares during the last quarter. Sendero Wealth Management LLC acquired a new position in shares of Ambev during the fourth quarter valued at about $40,000. Park Avenue Securities LLC raised its position in shares of Ambev by 130.9% in the 4th quarter. Park Avenue Securities LLC now owns 66,483 shares of the company’s stock valued at $123,000 after purchasing an additional 37,696 shares during the last quarter. Wynn Capital LLC boosted its stake in Ambev by 20.2% in the 4th quarter. Wynn Capital LLC now owns 97,790 shares of the company’s stock worth $181,000 after purchasing an additional 16,435 shares in the last quarter. Finally, Winthrop Advisory Group LLC boosted its stake in Ambev by 58.8% in the 4th quarter. Winthrop Advisory Group LLC now owns 24,634 shares of the company’s stock worth $46,000 after purchasing an additional 9,120 shares in the last quarter. 8.13% of the stock is owned by hedge funds and other institutional investors.

Ambev Trading Up 2.5 %

NYSE ABEV opened at $1.83 on Wednesday. Ambev S.A. has a 1 year low of $1.76 and a 1 year high of $2.72. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.20 and a quick ratio of 0.89. The company has a market capitalization of $28.75 billion, a PE ratio of 10.14, a P/E/G ratio of 5.23 and a beta of 1.05. The company has a fifty day moving average of $2.04 and a 200 day moving average of $2.19.

Ambev Cuts Dividend

The business also recently announced an annual dividend, which was paid on Thursday, January 9th. Stockholders of record on Monday, December 23rd were paid a $0.0414 dividend. The ex-dividend date of this dividend was Monday, December 23rd. This represents a dividend yield of 1.93%. Ambev’s payout ratio is 33.33%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on ABEV. StockNews.com began coverage on shares of Ambev in a report on Sunday. They issued a “buy” rating for the company. Bank of America downgraded Ambev from a “buy” rating to a “neutral” rating in a research note on Friday, January 17th. Finally, Barclays reduced their price objective on Ambev from $2.50 to $2.00 and set an “equal weight” rating for the company in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $2.45.

Ambev Company Profile

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith’s, and Kokanee brands.